Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
Introduction
Alzheimer's disease (AD) is the most common form of neurodegenerative dementia. Its hallmarks are neurofibrillary tangles and amyloid plaques, caused by hyperphosphorylated tau and amyloid beta (Aβ) protein, respectively (Lee et al., 2001). Growing evidence indicates that the 42-residue amyloid beta protein plays an essential role in the pathogenesis of AD. The amyloid cascade hypothesis proposes that the abnormal accumulation of Aβ inhibits synaptic function, gradually induces neuronal and glial changes, and initiates the process of neurodegeneration (Hardy and Selkoe, 2002).
Reduced synaptic function is one of the earliest measurable defects in AD (Walsh et al., 2002b). Although different assembly forms of Aβ may affect AD pathogenesis at different stages (Haass and Selkoe, 2007, Lambert et al., 1998, Walsh et al., 2002a), plaque numbers and insoluble Aβ levels do not appear to correlate with disease progression in the early stages of AD (McLean et al., 1999). Instead, many aspects of early AD pathogenesis are closely correlated with cerebral levels of soluble Aβ oligomers. For example, Aβ oligomers trigger various pathophysiological events associated with AD, such as alteration of synaptic plasticity by inhibiting long-term potentiation (LTP), facilitating long-term depression (LTD), causing the loss of dendritic spines, modulating the expression of 2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl) propanoic acid (AMPA) and N-methyl-D-aspartic acid (NMDA) receptors, and disturbing calcium homeostasis (Demuro et al., 2005, Green and LaFerla, 2008, Haass and Selkoe, 2007, Hsieh et al., 2006, Shankar et al., 2007, Snyder et al., 2005). They also have acute effects on synaptic function. For example, injection of soluble forms of human Aβ oligomer disrupts cognitive function in a rapid and transient manner (Cleary et al., 2005), and endogenous or exogenous Aβ antibodies can restore synaptic function and reverse the acute memory deficits in AD animal models (Billings et al., 2005, Dodart et al., 2002, Kotilinek et al., 2002).
Most previous studies have focused on the effects of Aβ oligomers on postsynaptic function, and it is still unclear which step(s) in presynaptic function is affected (Abramov et al., 2009, Berman et al., 2008, Calabrese et al., 2007, Moreno et al., 2009, Nimmrich et al., 2008, Puzzo et al., 2008). Synaptic vesicle components are recycled through a local exo-endocytic pathway in presynaptic nerve terminals, and recent studies have revealed some of the molecular details of this process (Dittman and Ryan, 2009, Murthy and De Camilli, 2003). The synaptic vesicle pool consists of a recycling pool, which includes a readily-releasable pool (RRP) and a reserve pool, and a resting pool that does not normally recycle. The size of the pool of vesicles that recycles and the kinetics of each of the recycling steps all play important roles in determining the efficacy of synaptic function. Therefore, uncovering the step(s) in synaptic vesicle trafficking that are affected by Aβ oligomers and the intracellular signaling pathways involved could identify suitable drug targets and lead to the development of new therapeutic interventions.
To examine the effect of soluble Aβ oligomers on presynaptic function, we treated cultured rat hippocampal neurons with nanomolar concentrations of Aβ oligomers. Using a quantitative kinetic analysis of the trafficking of synaptic vesicles, we were able to detect subtle alterations in multiple steps of trafficking and the intracellular signaling pathways involved, thus revealing how Aβ oligomers cause presynaptic dysfunction.
Section snippets
Materials
Synthetic Aβ peptide 1–42 was from Bachem (Bubendorf, Switzerland) and anti-beta amyloid monoclonal antibody (6E10) was purchased from Signet (Dedham, MA). NuPAGE 4–12% bis-Tris gel was from Invitrogen (Carlsbad, CA). Bafilomycin A1 and roscovitine were from Calbiochem (San Diego, CA). Calpain inhibitor III, hexafluoro-2-propanol (HFIP) and dimethyl sulfoxide (DMSO) were from Sigma (St. Louis, MO).
Aβ oligomers preparation
Aβ oligomers were prepared as described (Berman et al., 2008, Dahlgren et al., 2002). Synthetic Aβ
Aβ oligomers reduce the size of the functional recycling pool and increase that of the resting pool
To address the effect of Aβ oligomers on presynaptic function, we transfected cultured rat hippocampal neurons with vGlut–pHluorin (vGpH). vGpH harbors vesicular glutamate transporter 1 fused with pHluorin, a modified GFP with high pH sensitivity (Miesenbock et al., 1998, Sankaranarayanan et al., 2000, Voglmaier et al., 2006). When targeted to the synaptic vesicle lumen, vGpH is quenched and upon exocytosis the relatively basic pH of the extracellular space allows it to fluoresce. Its
Discussion
The data reported here demonstrate that nanomolar concentrations of synthetic Aβ oligomers cause defects in multiple presynaptic functions. Aβ oligomers treatment slowed endocytosis during as well as after stimulation, whereas the exocytotic rate was not affected. Repriming of the synaptic vesicles was also severely impaired. The total synaptic vesicle pool was not affected, although the recycling pool decreased, with a concomitant increase in the resting pool. The release probability of the
Acknowledgments
This research was supported by grants from the Korea Health Technology R&D Project (A092058) to SC funded by the Ministry of Health & Welfare, Republic of Korea and by grants from the Biomembrane Plasticity Research Center (no. 20100029395) to SC funded by the National Research Foundation of Korea and the Brain Research Center of the 21st Century Frontier Research Program (M103KV010009-06K2201-00910) to SC funded by the Ministry of Education & Science & Technology, Republic of Korea.
References (66)
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
Neuron
(2005)Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein
Mol. Cell. Neurosci.
(2007)Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress
Neurobiol. Dis.
(2007)Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability
J. Biol. Chem.
(2002)Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers
J. Biol. Chem.
(2005)Clathrin-mediated endocytosis is the dominant mechanism of vesicle retrieval at hippocampal synapses
Neuron
(2006)- et al.
Linking calcium to Abeta and Alzheimer's disease
Neuron
(2008) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss
Neuron
(2006)Dynamin and the actin cytoskeleton cooperatively regulate plasma membrane invagination by BAR and F-BAR proteins
Dev. Cell
(2005)- et al.
Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons
Neuroscience
(2007)
CDK5 serves as a major control point in neurotransmitter release
Neuron
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein
Int. J. Biochem. Cell Biol.
Vesicle pool mobilization during action potential firing at hippocampal synapses
Neuron
The use of pHluorins for optical measurements of presynaptic activity
Biophys. J.
Sorting nexin 9 interacts with dynamin 1 and N-WASP and coordinates synaptic vesicle endocytosis
J. Biol. Chem.
Clathrin-mediated endocytosis: membrane factors pull the trigger
Trends Cell Biol.
Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling
Neuron
PIP kinase Igamma is the major PI(4,5)P(2) synthesizing enzyme at the synapse
Neuron
Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses
Nat. Neurosci.
Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein
J. Neurochem.
Single-vesicle imaging reveals that synaptic vesicle exocytosis and endocytosis are coupled by a single stochastic mode
Proc. Natl. Acad. Sci. U. S. A.
Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism
Nat. Neurosci.
Studying vesicle cycling in presynaptic terminals using the genetically encoded probe synaptopHluorin
Nat. Protoc.
Glutamate regulates actin-based motility in axonal filopodia
Nat. Neurosci.
Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice
J. Neurosci.
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function
Nat. Neurosci.
p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo
J. Neurosci.
Quantal components of the end-plate potential
J. Physiol.
Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking
Nature
Molecular circuitry of endocytosis at nerve terminals
Annu. Rev. Cell Dev. Biol.
Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model
Nat. Neurosci.
The role of endocytosis in regulating the strength of hippocampal synapses
J. Physiol.
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide
Nat. Rev. Mol. Cell Biol.
Cited by (49)
Emerging Role of microRNAs in Dementia
2019, Journal of Molecular BiologyCitation Excerpt :At the pre-synapse, Aβ is reported to increase the potassium-evoked glutamate release and hence the network activity in the hippocampal slices [98]. Aβ interferes with the calpain–CDK5 pathway leading to defective endocytosis of synaptic vesicles [99,100]. This is proposed to be the mechanism by which Aβ alters the ratio of recycling pool and resting pool of synaptic vesicles and affects the release probability [99,100].
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
2019, Pharmacology and TherapeuticsCitation Excerpt :In addition to potentiating the release probability of the readily releasable pool of synaptic vesicles, Aβ impairs vesicle recycling by reducing the recycling pool and increasing the resting pool via the calpain-dependent increase of the activity of cyclin-dependent kinase 5 (Cdk5). Indeed, Cdk5 inhibitor exhibits a beneficial effect on the recovery of the size of the vesicle pool, providing a brake for the Aβ-induced deregulation of synaptic vesicle cycling (Park, Jang, & Chang, 2013). d-Serine is the dominant co-agonist of NMDA receptor-mediated synaptotoxicity.
Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
2018, Alzheimer's and DementiaCitation Excerpt :These effects occur without alterations in the total synaptic vesicle content of axon terminals. In a separate experiment, the effects of Aβ42 oligomers on the rate of endocytosis in individual synaptic boutons were analyzed, with endocytosis and reformation of synaptic vesicles found to be slowed down, leaving only 50% of released vesicles recycled back to the releasable pool [98]. Although the molecular mechanisms of delayed recovery of synaptic vesicles remain unclear, CDK5, known to regulate synaptic vesicle pool size [63], has been suggested to play a major role [98,132] (Fig. 3A–C).
Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid
2017, Neurobiology of DiseaseCitation Excerpt :Finally, since there weren't any differences in the phosphorylation levels of Tyr307 of the catalytic domain of PP2A we concluded that Aβ42O induced sustained kinase activity in depolarised hippocampal neurons. It is important to understand how the data from our experiments relate to the synaptic dysfunction in early AD patients and to offer an explanation of available data regarding the effects of Aβ42 in NT release and SV availability (Abramov et al., 2009; Billings et al., 2005; Kelly and Ferreira, 2007; Oddo et al., 2003; Park et al., 2013; Parodi et al., 2010; Puzzo et al., 2008; Ripoli et al., 2013; Russell et al., 2012). Our data suggest that in neurons exposed to Aβ42O, the sustained phosphorylation levels of SnpISer9 after neuronal activity would prevent SnpI from stabilising SVs to the reserve pool after depolarisation, promoting an increase in their availability and consequently in glutamate release.